Author: Becca Bucci
AMCP 2024
AAOS – American Academy of Orthopaedic Surgeons
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges
Therapeutic proteins (TP) – and more specifically monoclonal antibodies – are part of the therapeutic arsenal for the treatment of several diseases, providing effective and safe therapeutic solutions for patients. As part of the usual therapeutic practice, patients often receive drug combinations (TP/TP or TP/small molecules) and/or concomitant co-medications. Thus, drug-drug-interactions (DDIs) can be a … Continued
ACCAE (Asia Congress for Alternatives to Animal Experiments)
Biotech Showcase
BIO Partnering at JPM
Why you should select your drug formulation before starting clinical studies
Drug developers often rush through the discovery process to get into human testing. Most are so curious about their new target or molecule that they may forget that the pharmaceutical formulation process that can easily make or break their program. Once in human testing, revisiting these formulations is often time-consuming. By then, depending on drug … Continued
클라우드 컴퓨팅의 힘을 활용하여 워크플로를 간소화하는 방법을 알아보십시오!
Certara’s Phoenix Hosted package provides your PK scientists with a secured and validated Certara AWS workspace allowing for much quicker transit time from compliant data sources. PK/PD 모델링의 기초가 되는 복잡한 시간 기반 데이터를 관리하여 생산성을 향상시키고 규정 준수에 대한 요구사항을 지원합니다. Certara’s deployment experts can optimize the Phoenix application configuration for increased … Continued
RAPS sponsored webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months
Join us on November 10th for this webcast being held in partnership with RAPS. The Clinical Trials Regulation (CTR) for the European Union (EU) took effect on 1월 31, 2022. Sites and sponsors must now embrace the new regulations to successfully run clinical trials across the European Union. Beginning on January 31st, 2023, sponsors are … Continued
